Stephen L. Kopecky

10.8k total citations · 4 hit papers
149 papers, 7.8k citations indexed

About

Stephen L. Kopecky is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Stephen L. Kopecky has authored 149 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Cardiology and Cardiovascular Medicine, 42 papers in Surgery and 22 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Stephen L. Kopecky's work include Acute Myocardial Infarction Research (31 papers), Lipoproteins and Cardiovascular Health (25 papers) and Cardiac Imaging and Diagnostics (22 papers). Stephen L. Kopecky is often cited by papers focused on Acute Myocardial Infarction Research (31 papers), Lipoproteins and Cardiovascular Health (25 papers) and Cardiac Imaging and Diagnostics (22 papers). Stephen L. Kopecky collaborates with scholars based in United States, Canada and Japan. Stephen L. Kopecky's co-authors include Robert L. Frye, Cornelia M. Weyand, Jörg J. Goronzy, David R. Holmes, Bernard J. Gersh, Giovanna Liuzzo, Guy S. Reeder, R. Scott Wright, Michael D. McGoon and Jack P. Whisnant and has published in prestigious journals such as New England Journal of Medicine, Circulation and The Journal of Experimental Medicine.

In The Last Decade

Stephen L. Kopecky

147 papers receiving 7.4k citations

Hit Papers

The Natural History of Lone Atrial Fibrillation 1987 2026 2000 2013 1987 2014 2015 2016 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Natural History of Lone Atrial Fibrillation
    1987 660 citations Stephen L. Kopecky et al. profile →
  2. An assessment by the Statin Muscle Safety Task Force: 2014 update
    2014 346 citations Stephen L. Kopecky et al. Journal of clinical lipidology profile →
  3. Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
    2015 345 citations Stephen L. Kopecky et al. Journal of clinical lipidology profile →
  4. Testosterone and Cardiovascular Disease
    2016 279 citations Stephen L. Kopecky et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen L. Kopecky United States 40 4.0k 1.6k 1.4k 917 861 149 7.8k
Vijay Nambi United States 48 5.4k 1.3× 2.6k 1.7× 1.0k 0.7× 833 0.9× 1.3k 1.5× 309 9.3k
Iain Squire United Kingdom 52 5.3k 1.3× 1.2k 0.7× 595 0.4× 1.5k 1.7× 747 0.9× 190 8.8k
Tami L. Bair United States 47 3.7k 0.9× 1.6k 1.0× 460 0.3× 489 0.5× 556 0.6× 195 7.6k
Steen Z. Abildstrøm Denmark 36 4.1k 1.0× 1.3k 0.8× 476 0.3× 392 0.4× 1.3k 1.5× 110 6.7k
Renate B. Schnabel Germany 56 8.6k 2.1× 1.6k 1.0× 862 0.6× 1.5k 1.6× 1.1k 1.2× 294 12.8k
Márcio Sommer Bittencourt Brazil 33 2.3k 0.6× 1.7k 1.1× 859 0.6× 982 1.1× 1.8k 2.1× 250 6.4k
Joseph Hung Australia 41 2.8k 0.7× 1.2k 0.8× 352 0.2× 703 0.8× 613 0.7× 191 6.5k
José Carlos Nicolau Brazil 46 4.8k 1.2× 2.7k 1.7× 499 0.3× 917 1.0× 974 1.1× 339 9.3k
Joseph P. McConnell United States 42 2.0k 0.5× 3.0k 1.9× 954 0.7× 1.4k 1.5× 409 0.5× 109 7.9k
Josep Lupón Spain 43 4.1k 1.0× 906 0.6× 591 0.4× 505 0.6× 286 0.3× 247 5.9k

Countries citing papers authored by Stephen L. Kopecky

Since Specialization
Citations

This map shows the geographic impact of Stephen L. Kopecky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen L. Kopecky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen L. Kopecky more than expected).

Fields of papers citing papers by Stephen L. Kopecky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen L. Kopecky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen L. Kopecky. The network helps show where Stephen L. Kopecky may publish in the future.

Co-authorship network of co-authors of Stephen L. Kopecky

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen L. Kopecky. A scholar is included among the top collaborators of Stephen L. Kopecky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen L. Kopecky. Stephen L. Kopecky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Araoz, Philip A., Palak Sharma, Aidan F. Mullan, et al.. (2024). Triple Rule Out CT in the Emergency Department: Clinical Risk and Outcomes (Triple Rule Out in the Emergency Department). Academic Radiology. 32(3). 1297–1305. 1 indexed citations
2.
Kopecky, Stephen L., et al.. (2024). Navigating omega-3s. European Journal of Preventive Cardiology. 31(15). 1876–1877. 1 indexed citations
3.
Brewer, LaPrincess C., Donald Clark, Melvin R. Echols, et al.. (2023). Efficacy and Adherence Rates of a Novel Community‐Informed Virtual World‐Based Cardiac Rehabilitation Program: Protocol for the Destination Cardiac Rehab Randomized Controlled Trial. Journal of the American Heart Association. 12(23). e030883–e030883. 2 indexed citations
4.
Brewer, LaPrincess C., Jason S. Egginton, Joshua P. Slusser, et al.. (2022). A Community-Informed Virtual World-Based Cardiac Rehabilitation Program as an Extension of Center-Based Cardiac Rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention. 43(1). 22–30. 8 indexed citations
5.
Medina‐Inojosa, José R., Zhuo Li, Šárka Kunzová, et al.. (2022). Validation of a Brief Dietary Questionnaire for Use in Clinical Practice: Mini‐EAT (Eating Assessment Tool). Journal of the American Heart Association. 12(1). e025064–e025064. 17 indexed citations
6.
7.
Ostfeld, Robert J., Kathleen Allen, Karen Aspry, et al.. (2020). Vasculogenic Erectile Dysfunction: The Impact of Diet and Lifestyle. The American Journal of Medicine. 134(3). 310–316. 27 indexed citations
8.
Ye, Qian, et al.. (2020). Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Plasma Ceramide Levels. The American Journal of Cardiology. 128. 163–167. 12 indexed citations
9.
Deng, Yihong, et al.. (2020). Proprotein convertase subtilisin/kexin type 9 inhibitor utilization and low-density lipoprotein-cholesterol control in familial hypercholesterolemia. Journal of clinical lipidology. 15(2). 339–346. 4 indexed citations
10.
Meeusen, Jeffrey W., Leslie J. Donato, Stephen L. Kopecky, et al.. (2020). Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors. Clinica Chimica Acta. 511. 138–142. 35 indexed citations
11.
Aronow, Wilbert S., Amit V. Khera, Stephen L. Kopecky, et al.. (2017). The American Society for Preventive Cardiology Abstracts. Clinical Cardiology. 40(S1). 4–15. 1 indexed citations
12.
Nigam, Anil, Mario Talajic, Denis Roy, et al.. (2014). Fish Oil for the Reduction of Atrial Fibrillation Recurrence, Inflammation, and Oxidative Stress. Journal of the American College of Cardiology. 64(14). 1441–1448. 67 indexed citations
13.
Nigam, Anil, R. Scott Wright, Thomas G. Allison, et al.. (2005). Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. International Journal of Cardiology. 110(2). 153–159. 81 indexed citations
14.
15.
Nigam, Anil, Joseph G. Murphy, Ray W. Squires, et al.. (2003). Increased body mass index is associated with better short- but not long-term outcome following acute myocardial infarction despite an increased risk of recurrent events. Journal of the American College of Cardiology. 41(6). 533–534. 1 indexed citations
16.
Wright, R. Scott, et al.. (2003). Effect of Diabetes on the Mortality Risk of Cardiogenic Shock in a Community-Based Population. Mayo Clinic Proceedings. 78(5). 561–566. 11 indexed citations
17.
Aviles, Ronnier J., R. Scott Wright, Furman S. McDonald, et al.. (2002). Long-term prognosis of patients with clinical unstable angina pectoris without elevation of creatine kinase but with elevation of cardiac troponin i levels. The American Journal of Cardiology. 90(8). 875–878. 18 indexed citations
18.
Sgura, Fabio, et al.. (2001). Length of stay in myocardial infarction.. PubMed. 12–20, 25. 7 indexed citations
19.
Brilakis, Emmanouil S., R. Scott Wright, Stephen L. Kopecky, et al.. (2001). Bundle branch block as a predictor of long-term survival after acute myocardial infarction. The American Journal of Cardiology. 88(3). 205–209. 52 indexed citations
20.
Blackshear, Joseph L., Stephen L. Kopecky, Scott C. Litin, Robert E. Safford, & Stephen C. Hammill. (1996). Management of Atrial Fibrillation in Adults: Prevention of Thromboembolism and Symptomatic Treatment. Mayo Clinic Proceedings. 71(2). 150–160. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vijay Nambi Breakdown of academic impact, for papers by Iain Squire Breakdown of academic impact, for papers by Tami L. Bair Breakdown of academic impact, for papers by Steen Z. Abildstrøm Breakdown of academic impact, for papers by Renate B. Schnabel Breakdown of academic impact, for papers by Márcio Sommer Bittencourt Breakdown of academic impact, for papers by Joseph Hung Breakdown of academic impact, for papers by José Carlos Nicolau Breakdown of academic impact, for papers by Joseph P. McConnell Breakdown of academic impact, for papers by Josep Lupón
Rankless by CCL
2026